The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
High-throughput functional genomics using CRISPR-Cas9
Open accessAbstract
Forward genetic screens are powerful tools for the discovery and functional annotation of genetic elements. Recently, the RNA-guided CRISPR (clustered regularly interspaced short palindromic repeat)-associated Cas9 nuclease has been combined with genome-scale guide RNA libraries for unbiased, phenotypic screening. In this Review, we describe recent advances using Cas9 for genome-scale screens, including knockout approaches that inactivate genomic loci and strategies that modulate transcriptional activity. We discuss practical aspects of screen design, provide comparisons with RNA interference (RNAi) screening, and outline future applications and challenges.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the deficiencies of RNAi-based methods in the areas of reagent fidelity and scalability make it difficult to use this approach to accurately map drug target interactions across a large matrix of cell lines and drug treatments”
From A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor Evolution (2017) · cites this paper as Shalem et al., 2015
Experimental — accuracy not yet measuredIn the citing paper
“This has limited pooled screens largely to vetting genes for their potential impact on cell fitness”
From Protein Barcodes Enable High-Dimensional Single-Cell CRISPR Screens (2018) · cites this paper as Shalem et al., 2015
In the citing paper
“So far three distinct bacterial CRISPR systems have been identified; Type I, II and III, and it is the Type II system that has mainly been adapted for use in artificial gene regulation and genome editing (Kim and Kim 2014; Shalem, Sanjana and Zhang 2015).”
From Candida glabrata : new tools and technologies—expanding the toolkit (2015) · cites this paper as Shalem, Sanjana and Zhang 2015
In the citing paper
“The most commonly used CRISPR Type II system consists of a gRNA and an endonuclease, the CRISPR-associated (Cas) nuclease, Cas9, which cleaves the targeted chromosomal DNA in a site-specific manner triggering endogenous DNA repair systems resulting in genome modification (for an in-depth review, see Doudna and Charpentier 2014; Kim and Kim 2014; Shalem, Sanjana and Zhang 2015).”
From Candida glabrata : new tools and technologies—expanding the toolkit (2015) · cites this paper as Shalem, Sanjana and Zhang 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Self-citationRNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 7,118
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762
Self-citationImproved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
Self-citationGenome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
Self-citationRepurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 1,000
Cheng, M., Jin, X., Mu, L., Wang, F., Li, W., Zhong, X., Liu, X., Shen, W., Liu, Y., & Zhou, Y. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23776 · Cited by 13
Identification and propagation of haploid human pluripotent stem cells
Sagi, I., Egli, D. M., & Benvenisty, N. (2016) · Nature Protocols · doi:10.1038/nprot.2016.145 · Cited by 13
Wu, Q., Ferry, Q. R. V., Baeumler, T. A., Michaels, Y. S., Vitsios, D., Habib, O., Arnold, R. R., Jiang, X., Maio, S., Steinkraus, B. R., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00686-2 · Cited by 13
Addressing Cellular Heterogeneity in Cancer through Precision Proteomics
Waas, M., & Kislinger, T. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00338 · Cited by 13
Parallel reverse genetic screening in mutant human cells using transcriptomics
Gapp, B. V., Konopka, T., Penz, T., Dalal, V., Bürckstümmer, T., Bock, C., & Nijman, S. M. (2016) · Molecular Systems Biology · doi:10.15252/msb.20166890 · Cited by 12
Wang, J., Huo, J., Huang, H., Yao, C., & Yang, D. (2025) · Materials Today · doi:10.1016/j.mattod.2025.05.024 · Cited by 12
Micropeptides Encoded by Noncoding RNAs: Biological Functions and Roles in Diseases
Kong, J., Su, X., Zhou, C., Lin, W., Lin, A., & Tang, J. (2025) · Research · doi:10.34133/research.0967 · Cited by 12
PAF49: An RNA Polymerase I subunit essential for rDNA transcription and stabilization of PAF53
McNamar, R., Freeman, E., Baylor, K. N., Fakhouri, A. M., Huang, S., Knutson, B. A., & Rothblum, L. I. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104951 · Cited by 12
Genome-wide CRISPR screens and their applications in infectious disease
Srivastava, K., & Pandit, B. (2023) · Frontiers in Genome Editing · doi:10.3389/fgeed.2023.1243731 · Cited by 12
Lee, C. J. M., Autio, M. I., Zheng, W., Song, Y., Wang, S. C., Wong, D. C. P., Xiao, J., Zhu, Y., Yusoff, P., Yei, X., et al. (2024) · Circulation · doi:10.1161/circulationaha.122.061335 · Cited by 12
Genomic Diversity Illuminates the Environmental Adaptation of Drosophila suzukii
Feng, S., Degrey, S. P., Guédot, C., Schoville, S. D., & Pool, J. E. (2024) · Genome Biology and Evolution · doi:10.1093/gbe/evae195 · Cited by 12
The present and future of genome editing in cancer research
Li, X., Wu, R., & Ventura, A. (2016) · Human Genetics · doi:10.1007/s00439-016-1713-3 · Cited by 12
Genome-scale CRISPR screening for potential targets of ginsenoside compound K
Yang, Y., Liu, X., Li, S., Chen, Y., Zhao, Y., Wei, Y., Qiu, Y., Liu, Y., Zhou, Z., Han, J. S., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2234-5 · Cited by 12
Canver, M. C., Tripathi, P., Bullen, M. J., Olshansky, M., Kumar, Y., Wong, L. H., Turner, S. J., Lessard, S., Pinello, L., Orkin, S. H., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013772 · Cited by 12
Ding, J., Frantzeskos, A., & Orozco, G. (2021) · Seminars in Immunopathology · doi:10.1007/s00281-021-00887-4 · Cited by 12
CRISPR Technology in Cancer Diagnosis and Treatment: Opportunities and Challenges
Shademan, B., Masjedi, S., Karamad, V., Isazadeh, A., Söğütlü, F., rad, M. H. S., & Nourazarian, A. (2022) · Biochemical Genetics · doi:10.1007/s10528-022-10193-9 · Cited by 12
Shin, S., Kim, S. H., Park, J.-H., Lee, J. S., & Lee, G. M. (2022) · Metabolic Engineering · doi:10.1016/j.ymben.2022.03.017 · Cited by 12
A CRISPR-del-based pipeline for complete gene knockout in human diploid cells
Komori, T., Hata, S., Mabuchi, A., Genova, M., Harada, T., Fukuyama, M., Chinen, T., & Kitagawa, D. (2023) · Journal of Cell Science · doi:10.1242/jcs.260000 · Cited by 12
Li, C., Fu, J., Shao, S., & Luo, Z. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1011783 · Cited by 12
The applications of CRISPR screen in functional genomics
Qi, X., Zhang, J., Zhao, Y., Chen, T., Xiang, Y., Hui, J., Cai, D., Liu, Y., Xia, L., Yu, T., et al. (2016) · Briefings in Functional Genomics · doi:10.1093/bfgp/elw020 · Cited by 12
Jaiswal, A., Gopalacharyulu, P. V., Akimov, Y. A., Wennerberg, K., Kuznetsov, S. G., Tang, J. P., & Aittokallio, T. A. (2017) · Genome Medicine · doi:10.1186/s13073-017-0440-2 · Cited by 12
Noncanonical target-strand cytosine base editing via engineered Un1Cas12f1 platform
Song, Z., Guo, J., Fan, Z., Huang, S., Li, G., Zhao, Z., Chen, B., Huang, S., Zheng, W., Wei, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64562-0 · Cited by 11
Large-scale F0 CRISPR screens in vivo using MIC-Drop
Parvez, S., Brandt, Z. J., & Peterson, R. T. (2023) · Nature Protocols · doi:10.1038/s41596-023-00821-y · Cited by 13
CRISPR screens in mechanism and target discovery for AML
Tian, L., Liu, D., Guan, Z., Zhao, X., Li, S., Wang, X., Hou, R., Zheng, J., Cao, J., & Shi, M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29382 · Cited by 11
Directed mutagenesis in plants through genome editing using guide RNA library
Dutta, S., Paul, D., Das, A., Kumar, S., Roy, A., Barua, A., & Chinnusamy, V. (2024) · The Nucleus · doi:10.1007/s13237-024-00481-7 · Cited by 11
Beer, N. L., & Gloyn, A. L. (2016) · F1000Research · doi:10.12688/f1000research.8682.1 · Cited by 11
Valproic Acid Thermally Destabilizes and Inhibits SpyCas9 Activity
Cheng, X. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.08.014 · Cited by 11
Wang, C., & Rollins, J. A. (2021) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2021.103598 · Cited by 11
Three-dimensional CRISPR screening reveals epigenetic interaction with anti-angiogenic therapy
He, M. Y., Halford, M. M., Liu, R., Roy, J. P., Grant, Z. L., Coultas, L., Thio, N., Gilan, O., Chan, Y.-C., Dawson, M. A., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02397-3 · Cited by 11
Kim, D. V., Kulishova, L. M., Torgasheva, N. A., Melentyev, V. S., Dianov, G. L., Medvedev, S. P., Zakian, S. M., & Zharkov, D. O. (2021) · PLoS ONE · doi:10.1371/journal.pone.0257473 · Cited by 11
Baeten, J. T., Liu, W., Preddy, I., Zhou, N., & McNerney, M. E. (2022) · Leukemia · doi:10.1038/s41375-021-01491-z · Cited by 11
Vinceti, A., Lucia, R. R. D., Cremaschi, P., Perron, U., Karakoç, E., Mauri, L., Fernandez, C., Kluczynski, K. H., Anderson, D. S., & Iorio, F. (2023) · Cell Reports Methods · doi:10.1016/j.crmeth.2022.100373 · Cited by 12
dCas9-3xSRDX-mediated transcriptional repression in sugarcane
Hooghvorst, I., & Altpeter, F. (2023) · Plant Cell Reports · doi:10.1007/s00299-023-03062-1 · Cited by 11
Uncovering the bookshelves of CRISPR-based libraries: Advances and applications in cancer studies
Ruiz, N. Q., Oliveira, W. D. L., Esteca, M. V., Granato, D. C., & Simabuco, F. M. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104287 · Cited by 11
Grand Challenge in Psychopharmacology: Setting Priorities to Shape a Bright Future
Ciccocioppo, R. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00015 · Cited by 11
Québatte, M., & Dehio, C. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.08.002 · Cited by 11
CRISPR/Cas-based customization of pooled CRISPR libraries
Kweon, J., Kim, J., Jang, A.-H., & Kim, Y. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199473 · Cited by 11
Genome-wide CRISPR screens for the identification of therapeutic targets for cancer treatment
Xue, V. W., Wong, S. C. C., & Cho, W. C. S. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1820986 · Cited by 11
Zhu, Z., Ihle, N. T., Rejto, P. A., & Zarrinkar, P. P. (2016) · BMC Genomics · doi:10.1186/s12864-016-2807-y · Cited by 10
Unraveling of Central Nervous System Disease Mechanisms Using CRISPR Genome Manipulation
Vesikansa, A. (2018) · Journal of Central Nervous System Disease · doi:10.1177/1179573518787469 · Cited by 10
Nunes, C., Anckaert, J., Vloed, F. D., Wyn, J. D., Durinck, K., Vandesompele, J., Speleman, F., & Vermeirssen, V. (2024) · PLoS ONE · doi:10.1371/journal.pone.0296322 · Cited by 10
Applying CRISPR-Cas9 screens to dissect hematological malignancies
Iyer, D. N., Schimmer, A. D., & Chang, H. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022008966 · Cited by 10
Liying, Y., Lin, N., Ye, Y., Zhou, S. Y., Xu, Y., Chen, J., Zhuang, W., & Wang, Q. (2024) · Journal of Cancer · doi:10.7150/jca.93023 · Cited by 10
Truesdell, P. F., Chang, J. K., Villa, D. C., Dai, M., Zhao, Y., McIlwain, R., Young, S., Hiley, S. L., Craig, A. W., & Babak, T. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00673-z · Cited by 10
AnABlast: a newin silicostrategy for the genome-wide search of novel genes and fossil regions
Jiménez, J., Duncan, C. D. S., Gallardo‐Gómez, M., Mata, J., & Pérez‐Pulido, A. J. (2015) · DNA Research · doi:10.1093/dnares/dsv025 · Cited by 10
High-throughput screening to enhance oncolytic virus immunotherapy
Stojdl, D. F., Swift, S. L., & Allan, K. J. (2016) · Oncolytic Virotherapy · doi:10.2147/ov.s66217 · Cited by 10
From Reductionism to Holism: Toward a More Complete View of Development Through Genome Engineering
Delker, R. K., & Mann, R. S. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-63904-8_3 · Cited by 10
The integration of weighted gene association networks based on information entropy
Yang, F., Wu, D., Lin, L., Yang, J., Yang, T., & Zhao, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0190029 · Cited by 10
A solid‐phase transfection platform for arrayed CRISPR screens
Serçin, Ö., Reither, S., Roidos, P., Ballin, N., Palikyras, S., Baginska, A., Rein, K., Prada, M. L., Halavatyi, A. A., Winter, H., et al. (2019) · Molecular Systems Biology · doi:10.15252/msb.20198983 · Cited by 10
Liu, X., Yang, Y., Qiu, Y., Reyad‐ul‐Ferdous, M., Ding, Q., & Wang, Y. (2020) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2020.10.007 · Cited by 10
CRISPR Screens in Toxicology Research: An Overview
Sobh, A., Russo, M., & Vulpe, C. D. (2021) · Current Protocols · doi:10.1002/cpz1.136 · Cited by 10
Genome editing: An essential technology for cancer treatment
Tufail, M. (2022) · Medicine in Omics · doi:10.1016/j.meomic.2022.100015 · Cited by 10
Transcriptome modeling and phenotypic assays for cancer precision medicine
Jeong, E., Moon, S. U., Song, M., & Yoon, S. (2017) · Archives of Pharmacal Research · doi:10.1007/s12272-017-0940-z · Cited by 12
Minin, G. D., Postlmayr, A., & Wutz, A. (2018) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005950 · Cited by 10
Is microfluidics the “assembly line” for CRISPR-Cas9 gene-editing?
Ahmadi, F., Quach, A. B. V., & Shih, S. C. C. (2020) · Biomicrofluidics · doi:10.1063/5.0029846 · Cited by 10
High-throughput CRISPR technology: a novel horizon for solid organ transplantation
Li, X., Chen, Z., Ye, W., Yu, J., Zhang, X., Li, Y., Niu, Y., Ran, S., Wang, S., Luo, Z., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1295523 · Cited by 10
The establishment and regulation of human germ cell lineage
Yu, H., Wang, Z., Ma, J., Wang, R., Yao, S., Gu, Z., Lin, K., Li, J., Young, R. S., Yu, Y., et al. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04171-2 · Cited by 9
Mottram, L., Chakraborty, S., Cox, E., & Fleckenstein, J. M. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.01.016 · Cited by 9
Maity, S., Mukherjee, R., & Banerjee, S. (2022) · Molecular Biotechnology · doi:10.1007/s12033-022-00550-9 · Cited by 9
Pihlajamaa, P., Kauko, O., Sahu, B., Kivioja, T., & Taipale, J. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01444-6 · Cited by 11
Hazan, J. M., Amador, R., Ali-Nasser, T., Lahav, T., Shotan, S. R., Steinberg, M., Cohen, Z., Aran, D., Meiri, D., Assaraf, Y. G., et al. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-024-01015-8 · Cited by 10
CRISPR/Cas9, a universal tool for genomic engineering
Smirnov, A. V., Yunusova, A., Lukyanchikova, V., & Баттулин, Н. Р. (2016) · Vavilov Journal of Genetics and Breeding · doi:10.18699/vj16.175 · Cited by 11
Tool-Driven Advances in Neuropeptide Research from a Nematode Parasite Perspective
McCoy, C. J., Atkinson, L. E., Robb, E., Marks, N. J., Maule, A. G., & Mousley, A. (2017) · Trends in Parasitology · doi:10.1016/j.pt.2017.08.009 · Cited by 9
Developing precision medicine using scarless genome editing of human pluripotent stem cells
Steyer, B., Cory, E., & Saha, K. (2018) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2018.02.001 · Cited by 12
Turner, R. J., Gölz, S., Wollnik, C., Burkhardt, N., Sternberger, I., Andag, U., & Cornils, H. (2020) · SLAS DISCOVERY · doi:10.1177/2472555220915851 · Cited by 9
The milestone of genetic screening: Mammalian haploid cells
Sun, S., Zhao, Y., & Shuai, L. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.09.006 · Cited by 9
Uncovering the Distinct Properties of a Bacterial Type I-E CRISPR Activation System
Kcam, M. C. V., Tsong, A. J., & Chappell, J. (2022) · ACS Synthetic Biology · doi:10.1021/acssynbio.1c00496 · Cited by 9
Flavivirus–Host Interaction Landscape Visualized through Genome-Wide CRISPR Screens
Kanojia, A., Sharma, M., Shiraz, R., & Tripathi, S. (2022) · Viruses · doi:10.3390/v14102164 · Cited by 9
Liu, S., Yu, X., Wang, Q., Liu, Z., Xiao, Q., Hou, P., Hu, Y. J., Hou, W., Yang, Z., Guo, D., et al. (2017) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1705.05081 · Cited by 9
CRISPR-Cas9: A Precise Approach to Genome Engineering
Tanquero, J. S., Rodríguez-Pazmiño, Á. S., & Vispo, N. S. (2018) · Therapeutic Innovation & Regulatory Science · doi:10.1177/2168479018762798 · Cited by 9
Fluorescence Activated Cell Sorting (FACS) in Genome‐Wide Genetic Screening of Membrane Trafficking
Menasché, B. L., Crisman, L., Gulbranson, D. R., Davis, E. M., Yu, H., & Shen, J. (2018) · Current Protocols in Cell Biology · doi:10.1002/cpcb.68 · Cited by 10
Genome-wide approaches to unravelling host–virus interactions in Dengue and Zika infections
Carlin, A. F., & Shresta, S. (2018) · Current Opinion in Virology · doi:10.1016/j.coviro.2018.11.010 · Cited by 9
Therapeutic Target Discovery Using High-Throughput Genetic Screens in Acute Myeloid Leukemia
Liu, Q., Garcia, M., Wang, S., & Chen, C.-W. D. (2020) · Cells · doi:10.3390/cells9081888 · Cited by 9
Reducing False Positives in CRISPR/Cas9 Screens from Copy Number VariationsPreprint
Wu, A., Xiao, T., Fei, T., Liu, X. S., & Li, W. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/247031 · Cited by 9
HOXA9/MEIS1 targets in leukemia: reinforced signaling networks and therapeutic opportunities
Zhou, X., & Lu, R. (2022) · Haematologica · doi:10.3324/haematol.2022.281779 · Cited by 9
Protocol for isolation and proteostatic analysis of sub-populations of spermatogenic cells in mouse
Zou, Q., Yang, L., & Qi, H. (2022) · STAR Protocols · doi:10.1016/j.xpro.2022.101398 · Cited by 8
CRISPR-Cas9 knockout screen informs efficient reduction of the Komagataella phaffii secretome
Dalvie, N. C., Lorgeree, T. R., Yang, Y., Rodriguez‐Aponte, S. A., Whittaker, C. A., Hinckley, J. A., Clark, J. J., Rosario, A. M. D., Love, K. R., & Love, J. C. (2024) · Microbial Cell Factories · doi:10.1186/s12934-024-02466-2 · Cited by 8
Hu, S., Gan, M., Wei, Z., Shang, P., Song, L., Feng, J., Chen, L., Niu, L., Wang, Y., Zhang, S., et al. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1498641 · Cited by 9
Small Fish, Big Answers: Zebrafish and the Molecular Drivers of Metastasis
Martínez-López, M. F., & López‐Gil, J. F. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26030871 · Cited by 9
Wan, T.-C. R., Wei, L., Cheng, L.-H., Chin, W., Shen, J., Chan, F.-F., Kuang, Z., Wang, C., Wong, C. C.-L., & Wong, C. (2025) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2025.101502 · Cited by 8
Advances in CRISPR-enabled genome-wide screens in yeast
Robertson, N. R., Lee, S. C., Tafrishi, A., & Wheeldon, I. R. (2025) · FEMS Yeast Research · doi:10.1093/femsyr/foaf013 · Cited by 8
Kumar, A. V., Garg, V. K., & Buttar, H. S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-22300-6.00044-9 · Cited by 10
De Novo Gene Expression Reconstruction in Space
Lee, J. H. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.05.004 · Cited by 8
CRISPR/Cas9 in cancer: An attempt to the present trends and future prospects
Kaligotla, V. S. A., Jasti, T., & Kandra, P. (2021) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2200 · Cited by 8
Ge, C., You, W., Li, R., Li, W., & Shao, Y. (2021) · Journal of Basic Microbiology · doi:10.1002/jobm.202100120 · Cited by 8
CRI-SPA: a high-throughput method for systematic genetic editing of yeast libraries
Cachera, P., Olsson, H., Coumou, H. C., Jensen, M. L., Sánchez, B. J., Strucko, T., van den Broek, M. A., Daran, J.-M. G., Jensen, M. K., Sonnenschein, N., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad656 · Cited by 8
Mondal, P., Alyateem, G., Mitchell, A. V., & Gottesman, M. M. (2024) · Scientific Reports · doi:10.1038/s41598-024-66244-1 · Cited by 8
CRISPR-based genetic screens advance cancer immunology
Cao, Y., Li, X., Pan, Y., Wang, H., Yang, S., Hong, L., & Ye, L. (2024) · Science China Life Sciences · doi:10.1007/s11427-023-2571-0 · Cited by 8
Recent advances in CRISPR-Cas systems for colorectal cancer research and therapeutics
Sokhangouy, S. K., Alizadeh, F. L., Lotfi, M., Sharif, S., Ashouri, A., Yoosefi, Y., Qomi, S. B., & Abbaszadegan, M. R. (2024) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2024.2388777 · Cited by 8
Bahadır, S., Abdulla, M. F., Mostafa, K., Kavas, M., Hacıkamiloğlu, M. S., Kurt, O., & Yıldırım, K. (2024) · The Plant Genome · doi:10.1002/tpg2.20506 · Cited by 8
CRISPR/Cas9, a universal tool for genomic engineering
Smirnov, A. V., Yunusova, A., Lukyanchikova, V., & Баттулин, Н. Р. (2017) · Russian Journal of Genetics Applied Research · doi:10.1134/s2079059717040116 · Cited by 9
Next-generation omics technologies to explore microbial diversity
Sharma, A., Vashistt, J., & Shrivastava, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-824448-7.00026-7 · Cited by 8
Maeda, T., Kimura, Y., Nakano, T., & Yamaguchi, S. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.09.068 · Cited by 8
Rare Does Not Mean Worthless: How Rare Diseases Have Shaped Neurodevelopment Research in the NGS Era
Zaghi, M., Banfi, F., Bellini, E. N., & Sessa, A. (2021) · Biomolecules · doi:10.3390/biom11111713 · Cited by 8
Hu, M. Y., Lei, X. Y., Larson, J. D., McAlonis‐Downes, M., Ford, K. M., McDonald, D., Mach, K., Rusert, J. M., Wechsler‐Reya, R. J., & Mali, P. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121276 · Cited by 8
Takaki, S., Shimbo, T., Ikegami, K., Kitayama, T., Yamamoto, Y., Yamazaki, S., Mori, S., & Tamai, K. (2022) · Laboratory Investigation · doi:10.1038/s41374-022-00735-5 · Cited by 8
Identifying Lethal Dependencies with HUGE Predictive Power
Gimeno, M., José‐Eneriz, E. S., Rubio, A., Gárate, L., Miranda, E., Castilla, C., Agirre, X., Prósper, F., & Carazo, F. (2022) · Cancers · doi:10.3390/cancers14133251 · Cited by 8
Genome-Wide CRISPR Screening to Identify Mammalian Factors that Regulate Intron Retention
Scarborough, A. M., Govindan, A., & Conrad, N. K. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2521-7_16 · Cited by 8
CRISPR-Cas9 mediated genome editing of Huntington’s disease neurospheres
Han, J. Y., Seo, J., Choi, Y., Im, W., Ban, J., & Sung, J. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-08175-6 · Cited by 8
The N-peptide–binding mode is critical to Munc18-1 function in synaptic exocytosis
Shen, C., Liu, Y., Yu, H., Gulbranson, D. R., Kogut, I., Bilousova, G., Zhang, C., Stowell, M. H. B., & Shen, J. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005254 · Cited by 9
Metadata
- Authors
- Shalem, O., Sanjana, N. E., & Zhang, F.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Shalem, Ophir
- Zhang, Feng
- Venue
- Nature Reviews Genetics
- Published
- 2015-04-09
- Volume
- 16
- Issue
- 5
- Pages
- 299-311
- ISSN
- 1471-0056 (ISSN-L)
- 1471-0064
- PMC
- PMC4503232
- OpenAlex
- W2026592619
- Cited by
- 1,233
- References
- 130
- Citations by year
- 2026: 71 · 2025: 91 · 2024: 103 · 2023: 85 · 2022: 101 · 2021: 105 · 2020: 121 · 2019: 117 · 2018: 131 · 2017: 145 · 2016: 123 · 2015: 37
- FWCI
- 14.12
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Reviews Genetics (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- PMC
- Funders
- Klarman Family Foundation
- Simons Center for the Social Brain, Massachusetts Institute of Technology
- National Institute of Mental Health (DP1MH100706)
- National Human Genome Research Institute (K99HG008171)
- National Institute of Neurological Disorders and Stroke (R01NS073124)
- National Center for Chronic Disease Prevention and Health Promotion (DP1‑MH100706)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- CRISPR/Cas9, genome-wide screen, guide RNA library, forward genetic screen, gene knockout, transcriptional regulation, phenotypic screening, screen design, functional genomics
- MeSH terms
- Animals, Genetic Testing, Humans, Models, Genetic, Gene Library, Genomics, RNA Interference, Mice, Gene Knockout Techniques, High-Throughput Nucleotide Sequencing, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review